• Non ci sono risultati.

(1)Publications 1

N/A
N/A
Protected

Academic year: 2021

Condividi "(1)Publications 1"

Copied!
1
0
0

Testo completo

(1)

Publications

1. Petroni D.; Giacomelli C.; Taliani S.; Barresi E.; Robello M.; Daniele S.; Bartoli A.;

Burchielli S.; Pardini S.; Salvadori P.A.; Da Settimo F.; Martini C.; Trincavelli M.L.;

Menichetti L. Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer Synthesis and imaging of a new A2B PET tracer. Nuclear Medicine and Biology, 43(5), 309-317

2. Daniele S.; La Pietra V.; Barresi E.; Di Maro S.; Da Pozzo E.; Robello M.; La Motta C.;

Cosconati S.; Taliani S.; Marinelli L.; Novellino E.; Martini C.; Da Settimo F. Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute

(MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas. J.

Med. Chem., 2016, 59 (10), 4526–4538

Riferimenti

Documenti correlati

If the appropriate tracer is selected and suitable imaging conditions are used, the activity values measured in a region of interest (ROI) in the image should be most heavily

Potential gallium-68 tracers for imaging the heart with PET: evaluation of four gallium complexes with functio- nalized tripodal tris(salicylaldimine) ligands.. Gallium-68

The development of the first PET/CT prototype was initi- ated in 1992 with the objectives to integrate CT and PET within the same device, to use the CT images for the atten- uation

1. The role of Ga-67 scintigraphy in evaluating the results of therapy of lymphoma patients. Kostakoglu L, Leonard JP, Kuji I, et al. Comparison of fluorine-18 fluorodeoxyglucose

Clinical as- sessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer.. Kim CK, Gupta NC, Chandramouli B,

(13) studied 35 patients with esophageal cancer and demonstrated that FDG-PET had a sensitivity of 88% (7/8) and specificity of 93% (25/27) for detection of distant metastatic

addition of FDG-PET imaging to CT altered the surgical management in 41% of the patients, 27% by detecting CT- occult pancreatic carcinoma and 14% by identifying un- suspected

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dis- section for axillary staging in patients with early